Europe

The Emmes Corporation announced that it was awarded a contract from the National Institutes of Health to support pediatric clinical trials sponsored by the National Institute of Child Health and Human Development (NICHD). Valued at nearly $70 million, the 10‐1/2 year contract will support the NIH’s effort to improve the…
NuMedii, Inc announced the formation of a strategic partnership with Three Lakes Partners, LLC, to discover and advance new treatments for idiopathic pulmonary fibrosis (IPF) based on NuMedii’s Big Data intelligence technology. Idiopathic pulmonary fibrosis is a rare chronic progressive and usually fatal interstitial lung disease for which the origin is unknown.…
GlaxoSmithKline (GSK) opened its expanded antibiotics facility in Irvine in February 2016. The Irvine plant produces GSK's antibiotic drugs, including potassium clavulanate that is sold under the brand name Augmentin. Construction on the facility's expansion began in 2013, with the aim to expand the antibiotics production capacity to serve 100…
A ground-breaking collaborative project, driven by Epilepsy Scotland, together with two pharmaceutical companies, to develop and improve epilepsy services for adults in Dumfries & Galloway, was today recognised at the Scottish Parliament. The story of the transformation of care for epilepsy patients in the region, which includes the creation of…
As part of the United States regulatory approval process for new medicines, new uses of existing medicines and the continuous monitoring of safety, companies may be required to conduct additional studies and testing to support the safety and effectiveness of their medicines. In the European Union (EU) companies can be…
Page 1 of 5

Subscribe To Our Newsletter

Security Q:How many eyes has a typical person? (ex: 1)
Name:
Email: